Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “PD-1 Antibodies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Active Not RecruitingNCT02560636
What this trial is testing

Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer

Who this might be right for
Invasive Bladder Cancer
Royal Marsden NHS Foundation Trust 34
Early research (Phase 1)Study completedNCT02112032
What this trial is testing

Treatment of Advanced Melanoma With MK-3475 and Peginterferon

Who this might be right for
Melanoma
Hassane M. Zarour, MD 43
Testing effectiveness (Phase 2)Looking for participantsNCT05941507
What this trial is testing

Evaluate TROP2 ADC LCB84 Single Agent and in Combination With an Anti-PD-1 Ab in Advanced Solid Tumors

Who this might be right for
Advanced Solid Tumors
LigaChem Biosciences, Inc. 300
Not applicableStudy completedNCT06607809
What this trial is testing

Inflammatory Markers (ICC, MCVL) and Nivolumab Response: Predicting Immunotherapy Success in Metastatic RCC

Who this might be right for
Metastatic Renal Cell Carcinoma
Dr. Lutfi Kirdar Kartal Training and Research Hospital 99
Testing effectiveness (Phase 2)UnknownNCT04126993
What this trial is testing

Study of SHR-1210 Combined With Apatinib in the Treatment of Sarcoma

Who this might be right for
Sarcoma
Tianjin Medical University Cancer Institute and Hospital 80
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06751277
What this trial is testing

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

Who this might be right for
Recurrent or Metastatic Endometrial Cancer
xiang yang 26
Testing effectiveness (Phase 2)Study completedNCT05215067
What this trial is testing

A Phase II Trial of AK104 in Advanced Non-Small Cell Lung Cancer

Who this might be right for
Advanced Non-small Cell Lung Cancer
Akeso 44
Testing effectiveness (Phase 2)UnknownNCT06156878
What this trial is testing

PD-1 Inhibitor Plus Anti-EGFR Therapy And Radiotherapy in Locally Advanced NPC Resistant to Induction Chemotherapy

Who this might be right for
Nasopharyngeal Carcinoma
Fudan University 41
Testing effectiveness (Phase 2)Study completedNCT05792735
What this trial is testing

Neoadjuvant Cadonilimab Plus Chemotherapy Following Short-Course Radiotherapy in Locally Advanced Rectal Cancer

Who this might be right for
Locally Advanced Rectal Carcinoma
Shenzhen People's Hospital 27
Testing effectiveness (Phase 2)Active Not RecruitingNCT05522985
What this trial is testing

Toripalimab-based Neoadjuvant Therapy in LA-HNSCC

Who this might be right for
Head and Neck Squamous Cell CarcinomaNeoadjuvant Chemotherapy
Tianjin Medical University Cancer Institute and Hospital 122
Testing effectiveness (Phase 2)Study completedNCT04444167
What this trial is testing

Anti-PD-1/CTLA-4 Bispecific AK104 Plus Lenvatinib in First-line Advanced Hepatocellular Carcinoma

Who this might be right for
Hepatocellular Carcinoma
Akeso 59
Testing effectiveness (Phase 2)Temporarily pausedNCT03779100
What this trial is testing

Lenvatinib Plus PD-1 Antibody for Unresectable ICC

Who this might be right for
Intrahepatic Cholangiocarcinoma
Shi Ming 25
Testing effectiveness (Phase 2)Ended earlyNCT03287817
What this trial is testing

Cluster of Differentiation Antigen 19/22(CD19/22) CAR T Cells (AUTO3) for the Treatment of Diffuse Large B Cell Lymphoma

Who this might be right for
Relapsed/Refractory Diffuse Large B-Cell Lymphoma (DLBCL)
Autolus Limited 52
Testing effectiveness (Phase 2)UnknownNCT04967625
What this trial is testing

A Phase II Study of Sintilimab Combined With Anlotinib in Treatment of ED-SCLC

Who this might be right for
Small Cell Lung Cancer Extensive Stage
Zhejiang Cancer Hospital 23
Early research (Phase 1)Looking for participantsNCT05410717
What this trial is testing

CLDN6/GPC3/Mesothelin/AXL-CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
Stage IV Ovarian CancerTestis Cancer, RefractoryEndometrial Cancer Recurrent+1 more
Second Affiliated Hospital of Guangzhou Medical University 200
Early research (Phase 1)Active Not RecruitingNCT04606472
What this trial is testing

SI-B003, a PD-1/CTLA-4 Bispecific Antibody, in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT05155033
What this trial is testing

Phase II Trial of Combination Anti-PD-1 and Aldesleukin for Metastatic Melanoma and Renal Cell Carcinoma

Who this might be right for
Metastatic MelanomaAdvanced Locoregional MelanomaMetastatic Renal Cell Carcinoma+1 more
National Cancer Institute (NCI) 78
Testing effectiveness (Phase 2)UnknownNCT05664139
What this trial is testing

Recombinant Human Adenovirus Type 5 Injection Combined With PD-1 Monoclonal Antibody and Nab-paclitaxel in the Treatment of Patients With Liver Metastases From Malignant Melanoma

Who this might be right for
Malignant MelanomaLiver Metastases
Fujian Cancer Hospital 30
Early research (Phase 1)UnknownNCT03757936
What this trial is testing

A Phase I Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics of Anti-PD-1 Antibody (HLX10) in Combination With Avastin Biosimilar (HLX04) in Patients With Advanced Solid Tumors

Who this might be right for
Solid Tumor
Shanghai Henlius Biotech 30
Testing effectiveness (Phase 2)UnknownNCT06530784
What this trial is testing

Cryoablation Combined With PD-1 Antibody and Bevacizumab for Hepatocellular Carcinoma

Who this might be right for
Carcinoma, Hepatocellular
Shanghai Zhongshan Hospital 36
Next Page